$IMGN ImmunoGen, Inc. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ImmunoGen, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ImmunoGen, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in ImmunoGen, Inc. for free.
IRS Number: 042726691
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: IMGN
Company Address: 830 WINTER ST WALTHAM 02451
Former name: IMMUNOGEN INC, date of change: 1992-07-03
Market Capitalization: $205.16M
Prev close: $2.38
Average Daily Volume: 1,922,020
Days Low: $2.30
Year Low: $1.51
Year High: $9.78
ImmunoGen, Inc. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2021 | IMGN | ImmunoGen, Inc. | Wallace Richard John | Director | Option Exercise | A | 6.77 | 44,000 | 297,880 | 44,000 | |
| Jun 17 2021 | IMGN | ImmunoGen, Inc. | Wallace Richard John | Director | Option Exercise | A | 0.00 | 15,000 | 0 | 87,326 | |
| Apr 02 2021 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,666 | 0 | 109,876 | |
| Apr 02 2021 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,666 | 0 | 93,774 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Enyedy Mark J | Chief Executive Off ... | Option Exercise | A | 7.69 | 925,000 | 7,113,250 | 925,000 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Enyedy Mark J | Chief Executive Off ... | Gift | G | 0.00 | 10,000 | 0 | 429,017 | 439 K to 429 K (-2.28 %) |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | ALTSCHULLER Susan | SVP and CFO | Option Exercise | A | 7.69 | 163,798 | 1,259,607 | 163,798 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Wingrove Theresa | SVP of Regulatory A ... | Option Exercise | A | 7.69 | 121,905 | 937,449 | 121,905 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Coen Stacy Ann | Chief Business Offi ... | Option Exercise | A | 7.69 | 185,016 | 1,422,773 | 185,016 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Lentini Renee | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 7.69 | 80,800 | 621,352 | 80,800 | |
| Feb 09 2021 | IMGN | ImmunoGen, Inc. | Berkenblit Anna | SVP & Chief Medical ... | Option Exercise | A | 7.69 | 282,019 | 2,168,726 | 282,019 | |
| Jan 11 2021 | IMGN | ImmunoGen, Inc. | Lentini Renee | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 6.98 | 40,400 | 281,992 | 40,400 | |
| Jan 11 2021 | IMGN | ImmunoGen, Inc. | Lentini Renee | V.P.-Fin., Prin. Ac ... | Option Exercise | A | 6.98 | 40,400 | 281,992 | 40,400 | |
| Jan 05 2021 | IMGN | ImmunoGen, Inc. | Wingrove Theresa | VP of Regulatory Af ... | Grant | A | 4.04 | 2,659 | 10,742 | 75,750 | 73.1 K to 75.8 K (+3.64 %) |
| Jan 05 2021 | IMGN | ImmunoGen, Inc. | FOSTER DAVID G | V.P.-Fin., Prin. Ac ... | Grant | A | 4.04 | 362 | 1,462 | 38,274 | 37.9 K to 38.3 K (+0.95 %) |